Transforming Growth Factor-β Analysis of the VANISH Trial Cohort

Yuri Kim; Mitra Mastali; Jennifer E. Van Eyk; E. John Orav; Christoffer R. Vissing; Sharlene M. Day; Anna Axelsson Raja; Mark W. Russell; Kenneth Zahka; Harry M. Lever; Alexandre C. Pereira; Anne M. Murphy; Charles Canter; Richard G. Bach; Matthew T. Wheeler; Joseph W. Rossano; Anjali T. Owens; Henning Bundgaard; Lee Benson; Luisa Mestroni; Matthew R.G. Taylor; Amit R. Patel; Ivan Wilmot; Philip Thrush; Jonathan H. Soslow; Jason R. Becker; Christine E. Seidman; Carolyn Y. Ho; E. Kevin Hall; Lubna Choudhury; Elfriede Pahl; Kimberly Y. Lin

doi:10.1161/CIRCHEARTFAILURE.122.010314

Transforming Growth Factor-β Analysis of the VANISH Trial Cohort

Yuri Kim
, Mitra Mastali
, Jennifer E. Van Eyk
, E. John Orav
, Christoffer R. Vissing
, Sharlene M. Day
, Anna Axelsson Raja
, Mark W. Russell
, Kenneth Zahka
, Harry M. Lever
, Alexandre C. Pereira
, Anne M. Murphy
, Charles Canter
, Richard G. Bach
, Matthew T. Wheeler
, Joseph W. Rossano
, Anjali T. Owens
, Henning Bundgaard
, Lee Benson
, Luisa Mestroni

Matthew R.G. Taylor, Amit R. Patel, Ivan Wilmot, Philip Thrush, Jonathan H. Soslow, Jason R. Becker, Christine E. Seidman, Carolyn Y. Ho, E. Kevin Hall, Lubna Choudhury, Elfriede Pahl, Kimberly Y. Lin

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	E010314
Journal	Circulation: Heart Failure
Volume	16
Issue number	4
DOIs	https://doi.org/10.1161/CIRCHEARTFAILURE.122.010314
State	Published - Apr 1 2023

Keywords

TGF-β
angiotensin receptor blockers
hypertrophic cardiomyopathy

Access to Document

10.1161/CIRCHEARTFAILURE.122.010314

Cite this

Kim, Y., Mastali, M., Van Eyk, J. E., Orav, E. J., Vissing, C. R., Day, S. M., Axelsson Raja, A., Russell, M. W., Zahka, K., Lever, H. M., Pereira, A. C., Murphy, A. M., Canter, C., Bach, R. G., Wheeler, M. T., Rossano, J. W., Owens, A. T., Bundgaard, H., Benson, L., ... Lin, K. Y. (2023). Transforming Growth Factor-β Analysis of the VANISH Trial Cohort. Circulation: Heart Failure, 16(4), E010314. https://doi.org/10.1161/CIRCHEARTFAILURE.122.010314

@article{f5fd0d948b2c4f0db61140e6799d519d,

title = "Transforming Growth Factor-β Analysis of the VANISH Trial Cohort",

keywords = "TGF-β, angiotensin receptor blockers, hypertrophic cardiomyopathy",

author = "Yuri Kim and Mitra Mastali and \{Van Eyk\}, \{Jennifer E.\} and Orav, \{E. John\} and Vissing, \{Christoffer R.\} and Day, \{Sharlene M.\} and \{Axelsson Raja\}, Anna and Russell, \{Mark W.\} and Kenneth Zahka and Lever, \{Harry M.\} and Pereira, \{Alexandre C.\} and Murphy, \{Anne M.\} and Charles Canter and Bach, \{Richard G.\} and Wheeler, \{Matthew T.\} and Rossano, \{Joseph W.\} and Owens, \{Anjali T.\} and Henning Bundgaard and Lee Benson and Luisa Mestroni and Taylor, \{Matthew R.G.\} and Patel, \{Amit R.\} and Ivan Wilmot and Philip Thrush and Soslow, \{Jonathan H.\} and Becker, \{Jason R.\} and Seidman, \{Christine E.\} and Ho, \{Carolyn Y.\} and Hall, \{E. Kevin\} and Lubna Choudhury and Elfriede Pahl and Lin, \{Kimberly Y.\}",

note = "Funding Information: The VANISH trial (Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy) was funded by the National Institutes of Health/National Heart, Lung, and Blood Institute (P50HL112349; Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01912534). ",

year = "2023",

month = apr,

day = "1",

doi = "10.1161/CIRCHEARTFAILURE.122.010314",

language = "English",

volume = "16",

pages = "E010314",

journal = "Circulation: Heart Failure",

issn = "1941-3289",

number = "4",

}

Kim, Y, Mastali, M, Van Eyk, JE, Orav, EJ, Vissing, CR, Day, SM, Axelsson Raja, A, Russell, MW, Zahka, K, Lever, HM, Pereira, AC, Murphy, AM, Canter, C , Bach, RG, Wheeler, MT, Rossano, JW, Owens, AT, Bundgaard, H, Benson, L, Mestroni, L, Taylor, MRG, Patel, AR, Wilmot, I, Thrush, P, Soslow, JH, Becker, JR, Seidman, CE, Ho, CY, Hall, EK, Choudhury, L, Pahl, E & Lin, KY 2023, 'Transforming Growth Factor-β Analysis of the VANISH Trial Cohort', Circulation: Heart Failure, vol. 16, no. 4, pp. E010314. https://doi.org/10.1161/CIRCHEARTFAILURE.122.010314

TY - JOUR

T1 - Transforming Growth Factor-β Analysis of the VANISH Trial Cohort

AU - Kim, Yuri

AU - Mastali, Mitra

AU - Van Eyk, Jennifer E.

AU - Orav, E. John

AU - Vissing, Christoffer R.

AU - Day, Sharlene M.

AU - Axelsson Raja, Anna

AU - Russell, Mark W.

AU - Zahka, Kenneth

AU - Lever, Harry M.

AU - Pereira, Alexandre C.

AU - Murphy, Anne M.

AU - Canter, Charles

AU - Bach, Richard G.

AU - Wheeler, Matthew T.

AU - Rossano, Joseph W.

AU - Owens, Anjali T.

AU - Bundgaard, Henning

AU - Benson, Lee

AU - Mestroni, Luisa

AU - Taylor, Matthew R.G.

AU - Patel, Amit R.

AU - Wilmot, Ivan

AU - Thrush, Philip

AU - Soslow, Jonathan H.

AU - Becker, Jason R.

AU - Seidman, Christine E.

AU - Ho, Carolyn Y.

AU - Hall, E. Kevin

AU - Choudhury, Lubna

AU - Pahl, Elfriede

AU - Lin, Kimberly Y.

N1 - Funding Information: The VANISH trial (Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy) was funded by the National Institutes of Health/National Heart, Lung, and Blood Institute (P50HL112349; Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01912534).

PY - 2023/4/1

Y1 - 2023/4/1

KW - TGF-β

KW - angiotensin receptor blockers

KW - hypertrophic cardiomyopathy

UR - https://www.scopus.com/pages/publications/85152972372

U2 - 10.1161/CIRCHEARTFAILURE.122.010314

DO - 10.1161/CIRCHEARTFAILURE.122.010314

M3 - Article

C2 - 36999957

AN - SCOPUS:85152972372

SN - 1941-3289

VL - 16

SP - E010314

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

IS - 4

ER -

Transforming Growth Factor-β Analysis of the VANISH Trial Cohort

Keywords

Access to Document

Other files and links

Cite this